{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:06:58Z","timestamp":1791313618983,"version":"4.3.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008909","name":"Universitatea de Medicin\u0103 \u015fi Farmacie din T\u00eergu Mure\u0219","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.xhgg.2023.100183","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T18:13:12Z","timestamp":1676052792000},"page":"100183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The influence of NUDT15 variants on 6-mercaptopurine-induced neutropenia in Vietnamese pediatric acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"4","author":[{"given":"Mai-Lan","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Vu","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bich Tram","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen The Nguyen","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2023.100183_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MOH.0000000000000254","article-title":"Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders","volume":"23","author":"Chiang","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.xhgg.2023.100183_bib2","first-page":"82","article-title":"The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment","volume":"15","author":"Rudin","year":"2017","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.xhgg.2023.100183_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2023.100183_bib4","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2147\/DDDT.S210512","article-title":"Association between the c.415C\u00a0>\u00a0T, c.52G\u00a0>\u00a0A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.xhgg.2023.100183_bib5","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41436-019-0448-7","article-title":"Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry","volume":"21","author":"Schaeffeler","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2023.100183_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xhgg.2023.100183_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2018.07.021","article-title":"Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis","volume":"135","author":"Cargnin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xhgg.2023.100183_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4143\/crt.2017.283","article-title":"NUDT15 variants cause hematopoietic toxicity with low 6-TGN levels in children with acute lymphoblastic leukemia","volume":"50","author":"Yi","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.xhgg.2023.100183_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/pgs-2019-0177","article-title":"NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia","volume":"21","author":"Puangpetch","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.xhgg.2023.100183_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17512433.2021.1900729","article-title":"Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis","volume":"14","author":"Jena","year":"2021","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.xhgg.2023.100183_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xhgg.2023.100183_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/08880018.2022.2035027","article-title":"The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients","volume":"39","author":"Nghia","year":"2022","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.xhgg.2023.100183_bib13","series-title":"Children\u2019s Oncology Group","article-title":"AALL0932-Treatment of patients with\u00a0newly diagnosed standard risk B-lymphoblastic leukemia (B-ALL) or localized B-lineage lymphoblastic lymphoma (B-LLy)","author":"Angiolillo","year":"2010"},{"key":"10.1016\/j.xhgg.2023.100183_bib14","series-title":"Children\u2019s Oncology","article-title":"AALL1131-A phase III randomized trial for newly diagnosed high risk B-precursor acute lymphoblastic leukemia (ALL) testing clofarabine in the very high risk stratum","author":"Salzer","year":"2012"},{"key":"10.1016\/j.xhgg.2023.100183_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/tpj.2017.12","article-title":"Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia","volume":"18","author":"Tanaka","year":"2018","journal-title":"Pharmacogenomics J"}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247723000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247723000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:32:32Z","timestamp":1762979552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247723000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666247723000155"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2023.100183","relation":{},"ISSN":["2666-2477"],"issn-type":[{"value":"2666-2477","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of NUDT15 variants on 6-mercaptopurine-induced neutropenia in Vietnamese pediatric acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2023.100183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100183"}}